As of Oct 16
| -0.0367 / -9.18%|
The 6 analysts offering 12-month price forecasts for Alimera Sciences Inc have a median target of 2.00, with a high estimate of 2.50 and a low estimate of 0.49. The median estimate represents a +450.51% increase from the last price of 0.36.
The current consensus among 6 polled investment analysts is to Buy stock in Alimera Sciences Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.